Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan 23;12(1):25.
doi: 10.1186/s13014-017-0766-3.

Current controversies in radiotherapy for breast cancer

David Krug  1 , René Baumann  2 , Wilfried Budach  3 , Jürgen Dunst  2 , Petra Feyer  4 , Rainer Fietkau  5 , Wulf Haase  6 , Wolfgang Harms  7 , Marc D Piroth  8 , Marie-Luise Sautter-Bihl  9 , Felix Sedlmayer  10 , Rainer Souchon  11 , Frederik Wenz  12 , Rolf Sauer  5 ; Breast cancer expert panel of the German Society of Radiation Oncology (DEGRO)
Affiliations
Review

Current controversies in radiotherapy for breast cancer

David Krug et al. Radiat Oncol. .

Abstract

Multimodal treatment approaches have substantially improved the outcome of breast cancer patients in the last decades. Radiotherapy is an integral component of multimodal treatment concepts used in curative and palliative intention in numerous clinical situations from precursor lesions such as ductal carcinoma in situ (DCIS) to advanced breast cancer. This review addresses current controversial topics in radiotherapy with special consideration of DCIS, accelerated partial breast irradiation (APBI) and regional nodal irradiation (RNI) and provides an update on the clinical practice guidelines of the Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO).

Keywords: Accelerated partial breast irradiation; Breast cancer; Ductal carcinoma in situ; Regional nodal irradiation.

PubMed Disclaimer

References

    1. Budach W, Matuschek C, Bölke E, Dunst J, Feyer P, Fietkau R, et al. DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases. Strahlenther Onkol. 2015;191:623–33. doi: 10.1007/s00066-015-0843-1. - DOI - PMC - PubMed
    1. Harms W, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, et al. DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences. Strahlenther Onkol. 2016;192:199–208. doi: 10.1007/s00066-015-0939-7. - DOI - PMC - PubMed
    1. Sautter-Bihl ML, Sedlmayer F, Budach W, Dunst J, Feyer P, Fietkau R, et al. DEGRO practical guidelines: radiotherapy of breast cancer III—radiotherapy of the lymphatic pathways. Strahlenther Onkol. 2014;190:342–51. doi: 10.1007/s00066-013-0543-7. - DOI - PubMed
    1. Sedlmayer F, Sautter-Bihl ML, Budach W, Dunst J, Fastner G, Feyer P, et al. DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer. Strahlenther Onkol. 2013;189:825–33. doi: 10.1007/s00066-013-0437-8. - DOI - PMC - PubMed
    1. Souchon R, Sautter-Bihl ML, Sedlmayer F, Budach W, Dunst J, Feyer P, et al. DEGRO practical guidelines: radiotherapy of breast cancer II: radiotherapy of non-invasive neoplasia of the breast. Strahlenther Onkol. 2014;190:8–16. doi: 10.1007/s00066-013-0502-3. - DOI - PubMed